H.R. Hoogenboom

1.1k total citations · 1 hit paper
12 papers, 863 citations indexed

About

H.R. Hoogenboom is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, H.R. Hoogenboom has authored 12 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in H.R. Hoogenboom's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Glycosylation and Glycoproteins Research (7 papers) and Transgenic Plants and Applications (3 papers). H.R. Hoogenboom is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Glycosylation and Glycoproteins Research (7 papers) and Transgenic Plants and Applications (3 papers). H.R. Hoogenboom collaborates with scholars based in Netherlands, Belgium and United States. H.R. Hoogenboom's co-authors include Greg Winter, Carol Midgley, David P. Lane, Gregory C. Flynn, Ahuva Nissim, Ian M. Tomlinson, James D. Marks, Andrew D. Griffiths, Richard J. Youle and Jef C.M. Raus and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

H.R. Hoogenboom

12 papers receiving 812 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibody fragments from a ‘single pot’ phage display library as immunochemical reagents.

1994 468 citations Ahuva Nissim, H.R. Hoogenboom et al. The EMBO Journal profile →

Peers

H.R. Hoogenboom

RNMI

MB

IMMUN

ECOLO

ONCOL

Jane Wilton United Kingdom

Chun‐Wei Chang Australia

Peter Pack Germany

Karen Silence Belgium

Rene Hoet Netherlands

Ginger Chao United States

Hennie R. Hoogenboom Netherlands

Jörg Willuda Switzerland

D E Yelton United States

Anneke W. Reurs Netherlands

Jane Wilton United Kingdom

H.R. Hoogenboom

962 ×1.5

RNMI

922 ×1.4

MB

224 ×1.1

IMMUN

141 ×1.0

ECOLO

97 ×0.9

ONCOL

Citations per year, relative to H.R. Hoogenboom H.R. Hoogenboom (= 1×) peers Jane Wilton

Countries citing papers authored by H.R. Hoogenboom

Since Specialization

Citations

This map shows the geographic impact of H.R. Hoogenboom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.R. Hoogenboom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.R. Hoogenboom more than expected).

Fields of papers citing papers by H.R. Hoogenboom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.R. Hoogenboom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.R. Hoogenboom. The network helps show where H.R. Hoogenboom may publish in the future.

Co-authorship network of co-authors of H.R. Hoogenboom

This figure shows the co-authorship network connecting the top 25 collaborators of H.R. Hoogenboom. A scholar is included among the top collaborators of H.R. Hoogenboom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.R. Hoogenboom. H.R. Hoogenboom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Merchiers, Pascal, Peter Borghgraef, Ilse Dewachter, et al.. (2006). P4–279: Target specificity of nanobodies™ directed against amyloid peptides. Alzheimer s & Dementia. 2(3S_Part_19). 1 indexed citations

2.

Scheffer, G L, Anneke W. Reurs, Barry Jutten, et al.. (2002). Selection and characterisation of a phage-displayed human antibody (Fab) reactive to the lung resistance-related major vault protein. British Journal of Cancer. 86(6). 954–962. 7 indexed citations

3.

Debets, Reno, et al.. (2001). A phage display selected Fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes. Gene Therapy. 8(21). 1601–1608. 58 indexed citations

4.

Roovers, Rob C., Edith van der Linden, Adriaan P. de Bruı̈ne, Jan‐Willem Arends, & H.R. Hoogenboom. (2001). Identification of colon tumour-associated antigens by phage antibody selections on primary colorectal carcinoma. European Journal of Cancer. 37(4). 542–549. 20 indexed citations

5.

Haard, Hans J. de, Bert Kazemier, Arie van der Bent, et al.. (1998). Absolute conservation of residue 6 of immunoglobulin heavy chain variable regions of class IIA is required for correct folding. Protein Engineering Design and Selection. 11(12). 1267–1276. 32 indexed citations

6.

Groen, Guido van der, Piet J. Boender, M. J. M. Koolen, et al.. (1998). Selection of human anti-human immunodeficiency virus type 1 envelope single-chain antibodies from a peripheral blood cell-based phage repertoire.. Journal of General Virology. 79(12). 2883–2894. 7 indexed citations

7.

Lips, Cornelis J.M., Rudy M. Landsvater, Jo W.M. Höppener, et al.. (1995). From medical history and biochemical tests to presymptomatic treatment in a large MEN 2A family*. Journal of Internal Medicine. 238(4). 347–356. 16 indexed citations

8.

Nissim, Ahuva, H.R. Hoogenboom, Ian M. Tomlinson, et al.. (1994). Antibody fragments from a ‘single pot’ phage display library as immunochemical reagents.. The EMBO Journal. 13(3). 692–698. 468 indexed citations breakdown →

9.

Hoogenboom, H.R., James D. Marks, Andrew D. Griffiths, & Greg Winter. (1993). Building antibodies from their genes. PubMed. 36(1). 19–47. 5 indexed citations

10.

Nicholls, P J, V G Johnson, Sarah M. Andrew, et al.. (1993). Characterization of single-chain antibody (sFv)-toxin fusion proteins produced in vitro in rabbit reticulocyte lysate.. Journal of Biological Chemistry. 268(7). 5302–5308. 38 indexed citations

11.

Rybak, S.M., H.R. Hoogenboom, Harry Meade, et al.. (1992). Humanization of immunotoxins.. Proceedings of the National Academy of Sciences. 89(8). 3165–3169. 55 indexed citations

12.

Marks, James D., H.R. Hoogenboom, Andrew D. Griffiths, & Greg Winter. (1992). Molecular evolution of proteins on filamentous phage. Mimicking the strategy of the immune system.. Journal of Biological Chemistry. 267(23). 16007–16010. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact